RISIKOBASIERTE BEURTEILUNGSMUSTER

European patent · EP3154419 · In force

Register entry

Publication number
EP3154419
Application number
EP15800388
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 21, 2015
Published
Apr 19, 2017
Granted
Sep 11, 2024
Protection ends at the latest
May 20, 2035
Next annual fee due
May 31, 2027
IPC classes
G16H 50/30 (2018.01)
G16H 50/20 (2018.01)
G06F 18/22 (2023.01)
G06F 18/23 (2023.01)
Priority
US 201414291446 30.05.2014
PCT application
PCT/US2015/031965 21.05.2015
PCT publication
WO2015/183689 03.12.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jul 23, 2025

    Change

    Published in Swissreg on 23.07.2025

  3. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  4. Sep 18, 2024

    Change

    Published in Swissreg on 18.09.2024

  5. Sep 11, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 11.09.2024

  6. Sep 11, 2024

    Owner

    Owner
    Roche Diabetes Care GmbH, Sandhofer Straße 116, 68305 Mannheim, Germany → F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel

    Published in Swissreg on 11.09.2024

Parties

Holder

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventor

DUKE, David L.

Fishers, Indiana 46037, US

SONI, Abhishek

Noblesville, Indiana 46062, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.